Sleep Scan Recherche
Why ?
Sleep disorder in ICUs is a major health issue :
On more than 850 patients surveyed, the most frequent concern is the lack of sleep.
Up until now, recording sleep has been a real challenge in intensive care units :
On one hand due to technical difficulties
Polysomnographs are bulky, uncomfortable for patients, and disruptive for caregivers when administering care.
Additionally, they record but do not analyse, because the analysis and quantification of sleep in ICUs are specific, and conventional rules do not apply.
Lack of knowledge
Only a few doctors around the world know how to interpret this type of sleep. Consequently, studies on sleep in intensive care are difficult to conduct.
Somno Engineering offers you the SleepScanR :
This device includes a miniaturized EEG, an application with dynamic display and a sophisticated algorithm to analyze the sleep of resuscitated patients in real time.
- 1 miniaturised EEG recorder
- 1 application and a tablet
- 1 algorithm
Advantages
The device is very lightweight and offers optimal comfort for both patients and staff.
- It continuously records a one-channel EEG (C4 or C3) for 8 hours, as well as perceived sounds and light levels
- It is provided with an automatic sleep evaluation algorithm, which is validated in comparison with PSG
- Its measurement of sleep quality has been confirmed compared with subjective sleep assessment (patient-reported quality)
- This algorithm operates in near real-time and generates a factual sleep report at the end of the night, including total sleep time and sleep continuity index
- The EEG, sound, and light recordings can be downloaded in EDF standard format and are compatible with all standard PSG software
Benefits
of the SleepScanR
The SleepscanR makes it very easy to record and quantify sleep among many patients in critical condition.
In just 10 months, 160 nights of sleep were recorded in intensive care patients!
This is THE ideal solution for conducting large cohort studies on sleep in intensive care, randomized controlled trials or multicenter projects.
